Mamun Al Mahtab

Mamun Al Mahtab (nickname: Shwapnil; born 22 August 1970) is a Bangladeshi doctor, hepatologist, medical scientist, and author. With 290 publications in national and international peer-reviewed journals to his credit, Mahtab works as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).He has some scandals about wrong treatment.Some case are running still three years. Also did same mistake in 2023 and february 2024. Most pathetic mistake he did with a young doctor who died for professor's wrong treatment.

Lawsuits
He has been subject to accusations and lawsuits of medical malpractice and negligence that led to patients' deaths.

In May 2021, a Dhaka court ordered an investigation into allegations of negligence against three doctors, including Dr. Mamun Al Mahtab, leading to the death of another physician, Dr. Toufiq Enam. Physiotherapist Aktaruzzaman Mia filed a case with the Chief Metropolitan Magistrate's Court regarding the death of his son, Dr. Enam, on May 30 while undergoing treatment at BRB Hospital. Dr. Mahtab, a gastroenterologist at Labaid Hospital, was one of the three accused doctors. According to the allegations, Dr. Mahtab conducted an endoscopic retrograde cholangiopancreatography (ERCP) procedure on Dr. Enam after he developed complications following a surgery at Islami Bank Hospital. Dr. Mahtab admitted to treating Dr. Enam for hepatitis B and performing the ERCP with the patient's consent to avoid further surgery's high costs and risks. However, Dr. Enam's condition deteriorated, and he was transferred to BRB Hospital, where he passed away during an operation. Dr. Mahtab denied any negligence, claiming he was unaware of Dr. Enam's pre-existing conditions.

Bio
Mahtab is the chief researcher, and investigator for the GBPD060 clinical study of the Bangladesh-developed SARS-CoV-2 mRNA candidate. He is also the lead researcher on NASVAC's Phase I/II and III clinical studies. Mahtab was jointly awarded the 'Premio Nacional' from the Cuban Academy of Sciences for the discovery of NASVAC in 2019. He organizes awareness-raising programs on liver diseases across the country in addition to inventing the NASVAC drug aiming to offer an effective solution to Hepatitis B at an affordable price for mass people in Bangladesh.

Education
Mahtab graduated from Mymensingh Medical College in 1995. He was awarded an MSc in Gastroenterology from the University of London in 1998 and was subsequently awardeda n MD in Hepatology at Bangabandhu Sheikh Mujib Medical University in 2006. He is a Fellow of the Royal College of Physicians of London, the Royal College of Physicians of Ireland, the Indian College of Physicians and the American College of Gastroenterology.

Career
Mahtab is currently working as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).

He is currently associated with Anwer Khan Modern Hospital Limited, Dhaka and Labaid Specialized Hospital, Dhanmondi. He also serves at Anwer Khan Modern Medical College Hospital as a Specialist Hepatologist & Gastroenterologist and at Labaid Specialized Hospital, Dhanmondi as a Liver & Liver Cancer Specialist & Interventional Endoscopist Divisional Head.

Research
Mahtab is the principal investigator of the phase I/II and III clinical trials of NASVAC,  a new generic for chronic hepatitis B, which is already registered in Bangladesh, Cuba, Nicaragua, Ecuador, Belarus and Angola. It is the first drug to be developed and registered in Bangladesh. NASVAC is also the 'first novel molecule' to be registered by the Directorate General of Drug Administration of the Bangladesh Government.

Publications
Mahtab has compiled six books, namely 'Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases', published by Elsevier (2009), 'Comprehensive Text Book on Hepatitis B', published by Jaypee (2010), 'Fatty Liver Disease' (2012) and 'Hepatitis Management Update' (2015) published by McMillan and 'Text Book of Hepato-Gastroenterology' (2015) and 'Practical Hepato-Gastroenterology Prescriber' (2016) published by Jaypee.

Mahtab is serving on the Editorial Boards of several international journals in the fields of Hepatology and Gastroenterology including,
 * Euro-Asian Journal of Hepato-Gastroenterology (Journal of Euro-Asian Gastroenterological Association) (Co-Editor-in-Chief),
 * Hepatology International (journal of Asian Pacific Association for the Study of the Liver) (Associate Editor)
 * Journal of Clinical, Experimental Hepatology (journal of Indian Association for the Study of the Liver) (Editorial Board Member),
 * Hepatitis B Annual (Kalinga Gastroenterology Foundation, India) (Co-Editor-in-Chief) to name a few.

Affiliations
He is four times elected Secretary General of Association for the Study of the Liver Diseases Bangladesh (ASLDB) (the national Hepatology Association of Bangladesh). He is also foundering President of Bangabandhu Sheikh Mujib Medical University Hepatology Alumni Association and Executive Chairman of Forum for the Study of the Liver Bangladesh.

He is the founder General Secretary of Bangladesh Stem Cell and Regenerative Medicine Society.

He has organized several 'first time in Bangladesh' medical conferences including the first STEMCON in 2017 (1st international conference on stem cell therapy in Bangladesh) and first EndoVasculoCon in 2019 (1st live conference from endoscopy suit and vascular lab in the region).

He is Member Secretary of Sampritee Bangladesh.